1-18 of 18
Maher Albitar
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 4337: Predicting PD-L1 status in solid tumors using transcriptomic data and artificial intelligence algorithms

Ahmad Charifa, Alfonso Lam, Hong Zhang, Andrew Ip, Andrew Pecora, Stanley Waintraub, Deena Graham, Donna McNamara, Martin Gutierrez, Andrew Jennis, Ipsa Sharma, Jeffrey Estella, Wanlong Ma, Andre Goy, Maher Albitar
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 4337.
https://doi.org/10.1158/1538-7445.AM2023-4337
Published: 04 April 2023
View article titled, Abstract 4337: Predicting PD-L1 status in solid tumors using transcriptomic data and artificial intelligence algorithms
Journal Articles

Abstract 967: Real-world transcriptomic biomarkers as replacement for immunohistochemistry and FISH studies in breast cancer

Maher Albitar, Andre Goy, Andrew Pecora, Deena Graham, Donna Donna McNamara, Ahmad Ahmad Charifa, Andrew IP, Wanlong Ma, Stanley Waintraub
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 967.
https://doi.org/10.1158/1538-7445.AM2023-967
Published: 04 April 2023
View article titled, Abstract 967: Real-world transcriptomic biomarkers as replacement for immunohistochemistry and FISH studies in breast cancer
Journal Articles

Abstract 929: The molecular landscape of premenopausal versus postmenopausal breast cancer in patients without inherited predisposition mutations

Ahmad Charifa, Andre Goy, Andrew Pecora, Deena Graham, Donna McNamara, Andrew Ip, Wanlong Ma, Maher Albitar
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 929.
https://doi.org/10.1158/1538-7445.AM2023-929
Published: 04 April 2023
View article titled, Abstract 929: The molecular landscape of premenopausal versus postmenopausal breast cancer in patients without inherited predisposition mutations
Journal Articles

Abstract 4285: Genomics-driven clustering of disease-related biomarkers identifies therapeutic options in myelodysplastic syndromes (MDS)

Leylah M. Drusbosky, Kimberly E. Hawkins, Amy Meacham, Elizabeth Wise, Neeraj Kumar Singh, Chandan Kumar, Sumanth M. Vasista, Rakhi P. Suseela, Taher Abbasi, Shireen Vali, Kaoru Tohyama, Maher Albitar, Peter P. Sayeski, Christopher R. Cogle
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 4285.
https://doi.org/10.1158/1538-7445.AM2018-4285
Published: 01 July 2018
View article titled, Abstract 4285: Genomics-driven clustering of disease-related biomarkers identifies therapeutic options in myelodysplastic syndromes (MDS)
Journal Articles

Abstract 4524: Immunohistochemistry and alternative FISH testing in breast cancer with HER2 equivocal amplification

Sally Agersborg, Christopher Mixon, Thanh Nguyen, Sramila Aithal, Forrest Blocker, Lawrence Weiss, Robert Gasparini, Shiping Jiang, Wayne Chen, Gregory Hess, Maher Albitar
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 4524.
https://doi.org/10.1158/1538-7445.AM2018-4524
Published: 01 July 2018
View article titled, Abstract 4524: Immunohistochemistry and alternative FISH testing in breast cancer with <em>HER2</em> equivocal amplification
Journal Articles

Abstract 5618: Correlation between MET gene amplification and TP53 mutation in upregulating PD-L1 expression in EGFR wild-type lung cancer

Maher Albitar, Sucha Sudarsanam, Wanlong Ma, Shiping Jiang, Wayne Chen, Vincent Funari, Steven Brodie, Sally Agersborg
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 5618.
https://doi.org/10.1158/1538-7445.AM2017-5618
Published: 01 July 2017
View article titled, Abstract 5618: Correlation between MET gene amplification and TP53 mutation in upregulating PD-L1 expression in EGFR wild-type lung cancer
Journal Articles

Abstract 4015: A comparative study of PD-L1 IHC 22C3 and 28-8 FDA-approved diagnostic assays in cancer

Cory Batenchuk, Maher Albitar, Sucha Sudarsanam, Vladislav Chizhevsky, Chelsea Jin, Virginia A. Burns
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 4015.
https://doi.org/10.1158/1538-7445.AM2017-4015
Published: 01 July 2017
View article titled, Abstract 4015: A comparative study of PD-L1 IHC 22C3 and 28-8 FDA-approved diagnostic assays in cancer
Journal Articles

Abstract 292: Integrated analysis of ibrutinib resistance in chronic lymphocytic leukemia

Inhye E. Ahn, Adam Albitar, Chingiz Underbayev, Sarah Herman, Xin Tian, Susan Soto, Maryalice Stetler-Stevenson, Irina Maric, Mohammed Z. Farooqui, Maher Albitar, Adrian Wiestner
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 292.
https://doi.org/10.1158/1538-7445.AM2016-292
Published: 15 July 2016
View article titled, Abstract 292: Integrated analysis of ibrutinib resistance in chronic lymphocytic leukemia
Journal Articles

Abstract 3745: Detection of various ALK translocations using intragenic differential expression (IDE) in patients with non-small cell lung cancer

Heather R. Sanders, Hai-Rong Li, Eric D. Smith, Jennifer Jahn, Jay A. Scheerle, Anthony D. Sferruzza, Connie Novic, Aurelia M. Meloni-Ehrig, JoAnn C. Kelly, Maher Albitar
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 3745.
https://doi.org/10.1158/1538-7445.AM10-3745
Published: 15 April 2010
View article titled, Abstract 3745: Detection of various <em>ALK</em> translocations using intragenic differential expression (IDE) in patients with non-small cell lung cancer
Journal Articles

Abstract 3728: Two novel EML4-ALK fusion variants involving EML4 exon 17 identified in lung cancer

Hai-Rong Li, Heather R. Sanders, Anthony D. Sferruzza, Connie Novic, Aurelia M. Meloni-Ehrig, Maher Albitar
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 3728.
https://doi.org/10.1158/1538-7445.AM10-3728
Published: 15 April 2010
View article titled, Abstract 3728: Two novel <em>EML4-ALK</em> fusion variants involving <em>EML4</em> exon 17 identified in lung cancer
Journal Articles

Abstract 2723: Circulating microRNA as a biomarker for screening for hepatocellular carcinoma

Kevin Z. Qu, Ke Zhang, Maher Albitar
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 2723.
https://doi.org/10.1158/1538-7445.AM10-2723
Published: 15 April 2010
View article titled, Abstract 2723: Circulating microRNA as a biomarker for screening for hepatocellular carcinoma
Journal Articles

Abstract #1680: Evidence of immune disruption up to 9.8 years prior to diagnosis of chronic lymphocytic leukemia: A prospective study

Huei-Ting Tsai, Neil Caporaso, Robert Kyle, Jerry Katzmann, Angela Dispenzieri, Richard Hayes, Gerald Marti, Maher Albitar, Paolo Ghia, Vincent Rajkumar, Ola Landgren
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 1680.
Published: 01 May 2009
View article titled, Abstract #1680: Evidence of immune disruption up to 9.8 years prior to diagnosis of chronic lymphocytic leukemia: A prospective study
Journal Articles

Kit Inhibitor APcK110 Induces Apoptosis and Inhibits Proliferation of Acute Myeloid Leukemia Cells

Stefan Faderl, Ashutosh Pal, William Bornmann, Maher Albitar, David Maxwell, Quin Van, Zhenghong Peng, David Harris, Zhiming Liu, Inbal Hazan-Halevy, Hagop M. Kantarjian, Zeev Estrov
Journal: Cancer Research
Cancer Res (2009) 69 (9): 3910–3917.
https://doi.org/10.1158/0008-5472.CAN-08-0034
Published: 30 April 2009
View article titled, Kit Inhibitor APcK110 Induces Apoptosis and Inhibits Proliferation of Acute Myeloid Leukemia Cells
Open the PDF for Kit Inhibitor APcK110 Induces Apoptosis and Inhibits Proliferation of Acute Myeloid Leukemia Cells in another window
Journal Articles

AMN107, a novel aminopyrimidine inhibitor of Bcr-Abl, has significant activity in adult patients (pts) with imatinib-resistant bcr-abl positive chronic myeloid leukemia (CML)

Francis J. Giles, Oliver Ottmann, Jorge Cortes, Barbara Wassman, Lydia Wunderle, Susan O’Brien, Dan Jones, Andreas Hochhaus, Srdan Verstovsek, Patricia Rae, Kristine Rose, Leila Alland, Margaret Dugan, Paul Manley, Miloslav Beran, Maher Albitar, Hagop Kantarjian
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 935.
Published: 01 May 2005
View article titled, AMN107, a novel aminopyrimidine inhibitor of Bcr-Abl, has significant activity in adult patients (pts) with imatinib-resistant bcr-abl positive chronic myeloid leukemia (CML)
Journal Articles

Imatinib Mesylate Resistance Through BCR-ABL Independence in Chronic Myelogenous Leukemia

Nicholas J. Donato, Ji Y. Wu, Jonathan Stapley, Hui Lin, Ralph Arlinghaus, Bharat Aggarwal, Shishir Shishodin, Maher Albitar, Kimberly Hayes, Hagop Kantarjian, Moshe Talpaz
Journal: Cancer Research
Cancer Res (2004) 64 (2): 672–677.
https://doi.org/10.1158/0008-5472.CAN-03-1484
Published: 26 January 2004
View article titled, Imatinib Mesylate Resistance Through BCR-ABL Independence in Chronic Myelogenous Leukemia
Open the PDF for Imatinib Mesylate Resistance Through BCR-ABL Independence in Chronic Myelogenous Leukemia in another window
Journal Articles

Autocrine Interleukin-1β Production in Leukemia: Evidence for the Involvement of Mutated RAS6

Darrin M. Beaupre, Moshe Talpaz, Frank C. Marini, III, Richard J. Cristiano, Jack A. Roth, Zeev Estrov, Maher Albitar, Melvin H. Freedman, Razelle Kurzrock
Journal: Cancer Research
Cancer Res (1999) 59 (12): 2971–2980.
Published: 15 June 1999
View article titled, Autocrine Interleukin-1β Production in Leukemia: <subtitle>Evidence for the Involvement of Mutated <em>RAS</em>6</subtitle>
Open the PDF for Autocrine Interleukin-1β Production in Leukemia: <subtitle>Evidence for the Involvement of Mutated <em>RAS</em>6</subtitle> in another window
Journal Articles

ATM Mutations in B-Cell Chronic Lymphocytic Leukemia

Florencia Bullrich, Debora Rasio, Shinichi Kitada, Petr Starostik, Thomas Kipps, Michael Keating, Maher Albitar, John C. Reed, Carlo M. Croce
Journal: Cancer Research
Cancer Res (1999) 59 (1): 24–27.
Published: 01 January 1999
View article titled, <em>ATM</em> Mutations in B-Cell Chronic Lymphocytic Leukemia
Open the PDF for <em>ATM</em> Mutations in B-Cell Chronic Lymphocytic Leukemia in another window
Journal Articles

Deficiency of the ATM Protein Expression Defines an Aggressive Subgroup of B-Cell Chronic Lymphocytic Leukemia

Petr Starostik, Taghi Manshouri, Susan O'Brien, Emil Freireich, Hagop Kantarjian, Mohammad Haidar, Susan Lerner, Michael Keating, Maher Albitar
Journal: Cancer Research
Cancer Res (1998) 58 (20): 4552–4557.
Published: 01 October 1998
View article titled, Deficiency of the ATM Protein Expression Defines an Aggressive Subgroup of B-Cell Chronic Lymphocytic Leukemia
Open the PDF for Deficiency of the ATM Protein Expression Defines an Aggressive Subgroup of B-Cell Chronic Lymphocytic Leukemia in another window